Increased incidence of choroid plexus carcinoma due to the germline TP53 R337H mutation in southern Brazil

PLoS ONE

Volumn 6, Issue 3, 2011, Pages

  Custodio, Gislaine ^a   Taques, Guilherme R ^a   Figueiredo, Bonald C ^a   Gugelmin, Elizabeth S ^a   Figueiredo, Mirna M Oliveira ^a   Watanabe, Flora ^b   Pontarolo, Roberto ^c   Lalli, Enzo ^d,e   Torres, Luiz Fernando Bleggi ^a  

^a INSTITUTO DE PESQUISA PELÉ PEQUENO PRÍNCIPE   (Brazil)

^b Pequeno Principe Hospital   (Brazil)

^c FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^d INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^e UNIVERSITÉ CÔTE D'AZUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PRIMER DNA;

ADOLESCENT; ARTICLE; BRAIN CANCER; BRAZIL; CANCER INCIDENCE; CHILD; CHOROID PLEXUS CARCINOMA; CHOROID PLEXUS PAPILLOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; FAMILIAL CANCER; FEMALE; GENE DOSAGE; GENE MUTATION; GERMLINE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; INFANT; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SEQUENCE ANALYSIS; SURVIVAL RATE; TUMOR SUPPRESSOR GENE; WILD TYPE; CHOROID PLEXUS TUMOR; GENETICS; HETEROZYGOTE; INCIDENCE; MUTATION; NUCLEOTIDE SEQUENCE;

BASE SEQUENCE; BRAZIL; CHOROID PLEXUS NEOPLASMS; DNA PRIMERS; GERM-LINE MUTATION; HETEROZYGOTE; HUMANS; INCIDENCE; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 79952933734     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018015     Document Type: Article

References (32)

1. Berger C, Thiesse P, Lellouch-Tubiana A, Chantal K, Pierre-Kahn A, et al. (1998) Choroid plexus carcinoma in childhood: clinical features and prognostic factors. Neurosurgery 42: 470-475.
2. Aguzzi A, Brandner S, Paulus W, (2000) Choroid plexus tumors. Pathology and genetics- tumors of the nervous system Lyon IARC Press.
3. Melo ELA, Garcia MRT; Fernandes RY, de Barros NG, Cerri GG, et al. (2003) Lesões expansivas do plexo coróide. Radiol Bras 36: 379-384.
4. Chow E, Reardon DA, Shah AB, Jenkins JJ, Langston J, et al. (1999) Pediatric choroid plexus neoplasms. Int J Radiat Oncol Biol Phys 44: 249-254.
5. McManamy CS, Pears J, Weston CL, Hanzely Z, Ironside JW, et al. (2007) Nodule formation and desmoplasia in Medulloblastomas - Defining the nodular/desmoplastic variant and its biological behavior. Brain Pathol 17: 151-164.
6. Gessi M, Giangaspero F, Pietsch T, (2003) Atypical teratoid/rhabdoid tumors and choroide plexus tumors: when genetics "surprise" pathology. Brain Pathol 13: 409-414.
7. Tabori U, Shlien A, Baskin B, Levitt S, Ray P, et al. (2010) TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. J Clin Oncol 28: 1995-2001.
8. Bleggi-Torres LF, Noronha L, Scheffel DLH, Pinheiro DL, Gugelmin ES, (2004) Tumores de Plexo coróide. Estudo epidemiológico comparativo de 24 casos. Arq Neuropsiquiatr 62: 127-130.
9. Ribeiro RC, Sandrini F, Figueiredo B, Zambetti GP, Michalkiewicz E, et al. (2001) An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma. Proc Natl Acad Sci USA 98: 9330-9335.
10. Figueiredo BC, Sandrini R, Zambetti GP, Pereira RM, Cheng C, et al. (2006) Penetrance of adrenocortical tumours associated with the germline TP53 R337H mutation. J Med Genet 43: 91-96.
11. Pianovski MA, Maluf EM; de Carvalho DS, Ribeiro RC, Rodriguez-Galindo C, et al. (2005) Mortality rate of adrenocortical tumors in children under 15 years of age in Curitiba, Brazil. Pediatr Blood Cancer 47: 56-60.
12. Wolff J, Sajedi M, Brant R, Coppes MJ, Egeler RM, (2002) Choroid plexus tumours. British Journal of Cancer 87: 1086-1091.
13. Parkin DM, Stiller CA, Draper GJ, Bieber CA, (1988) The international incidence of childhood cancer. Int J Cancer 42: 511-520.
14. Ogawa O, Eccles MR, Szeto J, McNoe LA, Yun K, et al. (1993) Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 362: 749-751.
15. Farrugia A, Keyser C, Ludes B, (2010) Efficiency evaluation of a DNA extraction and purification protocol on archival formalin-fixed and paraffin-embedded tissue. Forensic Sci Int 194: e25-e28.
16. Birch JM, Hartley AL, Tricker KJ, Prosser J, Condie A, et al. (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298-1304.
17. Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, et al. (2009) 2009 Version of the Chompret Criteria for Li Fraumeni Syndrome. J Clin Oncol 27: e108-e110.
18. Digiammarino EL, Lee AS, Cadwell C, Zhang W, Bothner B, et al. (2002) A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer. Nat Struct Biol 9: 12-16.
19. Knudson AG, (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823.
20. Assumpção JG, Seidinger AL, Mastellaro M, Ribeiro RC, Zambetti GP, et al. (2008) Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 8: 357.
21. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, et al. (2007) The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol 114: 97-109.
22. Ang LC, Taylor AR, Bergin D, Kaufmann JC, (1990) An immunohistochemical study of papillary in the central nervous system. Cancer 32: 131-134.
23. Gottschalk J, Jautzke G, Paulus W, Goebel S, Cervos-Navarro J, (1993) The use of immunomorphology to differentiate choroid plexus tumors from metastatic carcinomas. Cancer 72: 1343-1349.
24. Bergsagel DJ, Finegold MJ, Butel JS, Kupsky WJ, Garcea RL, (1992) DNA sequences similar to those of simian virus 40 in ependymomas and choroid plexus tumors in childhood. N Engl J Med 9: 988-993.
25. Levine AJ, (2009) The common mechanisms of transformation by the small DNA tumor viruses: The inactivation of tumor suppressor gene products: p53. Virology 384: 285-293.
26. Soria C, Estermann FE, Espantman KC, O'Shea CC, (2010) Heterochromatin silencing of p53 target genes by a small viral protein. Nature 466: 1076-1081.
27. McEvoy AW, Harding BN, Phipps KP, Ellison DW, Elsmore AJ, et al. (2000) Management of choroid plexus tumours in children: 20 years experience at a single neurosurgical centre. Pediatr Neurosurg 32: 192-199.
28. Pierga JY, Kalifa C, Terrier-Lacombe MJ, Habrand JL, Lemerle J, (1993) Carcinoma of the choroid plexus: a pediatric experience. Med Ped Oncol 21: 480-487.
29. Latronico AC, Pinto EM, Domenice S, Fragoso MC, Martin RM, et al. (2001) An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors. J Clin Endocrinol Metab 86: 4970-4973.
30. Pinto EM, Billerbeck AE, Fragoso MC, Mendonca BB, Latronico AC, (2005) Deletion mapping of chromosome 17 in benign and malignant adrenocortical tumors associated with the Arg337His mutation of the p53 tumor suppressor protein. J Clin Endocrinol Metab 90: 2976-2981.
31. Mitchel RE, Jackson JS, Carlisle SM, (2004) Upper dose thresholds for radiation-induced adaptive response against cancer in high-dose-exposed, cancer-prone, radiation-sensitive Trp53 heterozygous mice. Radiat Res 162: 20-30.
32. Heymann S, Delaloge S, Rahal A, Caron O, Frebourg T, et al. (2010) Radio-induced malignancies after breast cancer postoperative radiotherapy in patients with Li-Fraumeni syndrome. Radiat Oncol 5: 104.